ARTICLE | Company News
Allergopharma Joachim Ganzer KG, Pharmacia & Upjohn Diagnostics AB deal
December 13, 1999 8:00 AM UTC
Allergopharma received an option to acquire co-exclusive rights to immunotherapeutic applications of P&U. s non-aliphatic forms of recombinant birch pollen allergen. Allergopharma will conduct Phase I...